Literature DB >> 3029406

Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins.

L E Henderson, R C Sowder, G W Smythers, S Oroszlan.   

Abstract

The viral core proteins (p15, p26, p11, and p9) of equine infectious anemia virus (EIAV) (Wyoming strain) were purified by reverse-phase high-pressure liquid chromatography. Each purified protein was analyzed for amino acid content, N-terminal amino acid sequence, C-terminal amino acid sequence, and phosphoamino acid content. The results of N- and C-terminal amino acid sequence analysis of each gag protein, taken together with the nucleotide sequence of the EIAV gag gene (R. M. Stephens, J. W. Casey, and N. R. Rice, Science 231:589-594, 1986), show that the order of the proteins in the precursor is p15-p26-*-p11-p9, where a pentapeptide also found in the virus is represented by the asterisk. The data are in complete agreement with the predicted structure of the gag polyprotein and show the peptide bonds cleaved during proteolytic processing. The N-terminus of p15 is blocked to Edman degradation. The p11 protein is identical to the nucleic acid-binding protein of EIAV previously isolated (C. W. Long, L. E. Henderson, and S. Oroszlan, Virology 104:491-496, 1980). High-titer rabbit antiserum was prepared against each purified protein. These antisera were used to detect the putative gag precursor (Pr55gag) and intermediate cleavage products designated Pr49 (p15-p26-*-p11), Pr40 (p15-p26), and Pr35 (p26-*-p11) in the virus and in virus-infected cells. High-titer antisera to EIAV p15 and p26 showed cross-reactivity with the homologous protein of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029406      PMCID: PMC254072          DOI: 10.1128/JVI.61.4.1116-1124.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Separation of phosphohydroxyamino acids by high-performance liquid chromatography.

Authors:  J C Yang; J M Fujitaki; R A Smith
Journal:  Anal Biochem       Date:  1982-05-15       Impact factor: 3.365

2.  Isolation and comparative biochemical properties of the major internal polypeptides of equine infectious anemia virus.

Authors:  R C Montelaro; N Lohrey; B Parekh; E W Blakeney; C J Issel
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

3.  Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational proteins modification.

Authors:  L E Henderson; H C Krutzsch; S Oroszlan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

4.  Terminal amino acid sequences and proteolytic cleavage sites of mouse mammary tumor virus env gene products.

Authors:  L E Henderson; R Sowder; G Smythers; S Oroszlan
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

5.  Biological characterization of the virus causing leukoencephalitis and arthritis in goats.

Authors:  O Narayan; J E Clements; J D Strandberg; L C Cork; D E Griffin
Journal:  J Gen Virol       Date:  1980-09       Impact factor: 3.891

6.  Primary structure analysis of the major internal protein p24 of human type C T-cell leukemia virus.

Authors:  S Oroszlan; M G Sarngadharan; T D Copeland; V S Kalyanaraman; R V Gilden; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

7.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

8.  RNA-dependent DNA polymerase associated with equine infectious anemia virus.

Authors:  B G Archer; T B Crawford; T C McGuire; M E Frazier
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103

9.  In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid.

Authors:  A M Schultz; S Oroszlan
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

10.  Primary structure of the low molecular weight nucleic acid-binding proteins of murine leukemia viruses.

Authors:  L E Henderson; T D Copeland; R C Sowder; G W Smythers; S Oroszlan
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

View more
  40 in total

1.  Evolution of feline immunodeficiency virus Gag proteins.

Authors:  Evan Burkala; Mary Poss
Journal:  Virus Genes       Date:  2007-01-30       Impact factor: 2.332

2.  Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src.

Authors:  J W Wills; R C Craven; R A Weldon; T D Nelle; C R Erdie
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  The topoisomerase I inhibitor, camptothecin, inhibits equine infectious anemia virus replication in chronically infected CF2Th cells.

Authors:  E Priel; S D Showalter; M Roberts; S Oroszlan; D G Blair
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.

Authors:  M A Accola; S Höglund; H G Göttlinger
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.

Authors:  K Wiegers; G Rutter; H Kottler; U Tessmer; H Hohenberg; H G Kräusslich
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

6.  Standardized and simplified nomenclature for proteins common to all retroviruses.

Authors:  J Leis; D Baltimore; J M Bishop; J Coffin; E Fleissner; S P Goff; S Oroszlan; H Robinson; A M Skalka; H M Temin
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

7.  Viral DNA in horses infected with equine infectious anemia virus.

Authors:  N R Rice; A S Lequarre; J W Casey; S Lahn; R M Stephens; J Edwards
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Inhibitory activity of the equine infectious anemia virus major 5' splice site in the absence of Rev.

Authors:  W Tan; M Schalling; C Zhao; M Luukkonen; M Nilsson; E M Fenyö; G N Pavlakis; S Schwartz
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Immunological characterization of the gag gene products of bovine immunodeficiency virus.

Authors:  J K Battles; M Y Hu; L Rasmussen; G J Tobin; M A Gonda
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Solution structure of the equine infectious anemia virus p9 protein: a rationalization of its different ALIX binding requirements compared to the analogous HIV-p6 protein.

Authors:  Alok Sharma; Karsten Bruns; René Röder; Peter Henklein; Jörg Votteler; Victor Wray; Ulrich Schubert
Journal:  BMC Struct Biol       Date:  2009-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.